ARKG Holdings of EXAS
Exact Sciences Corp.
Exact Sciences Corporation is a molecular diagnostics company specializing in the detection and prevention of certain types of cancer. The company makes money by developing and selling non-invasive screening tests, such as Cologuard, for early cancer detection, primarily generating revenue through product sales and service agreements with healthcare providers.
Trades of EXAS in ARKG
The ten most recent trades of Exact Sciences Corp. in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Nov 20, 2024 | Sell | $486,737 | 10.40% | 0.04% |
| Nov 18, 2024 | Sell | $1,151,549 | 20.90% | 0.10% |
| Nov 13, 2024 | Sell | $2,040,848 | 26.50% | 0.16% |
| Nov 12, 2024 | Sell | $2,472,975 | 24.77% | 0.18% |
| Sep 11, 2024 | Sell | $953,467 | 7.14% | 0.07% |
| Aug 07, 2024 | Sell | $2,574,950 | 17.37% | 0.19% |
| Jun 20, 2024 | Sell | $7,000,768 | 8.16% | 0.52% |
| Jun 10, 2024 | Sell | $2,184,683 | 2.35% | 0.16% |
| Jun 06, 2024 | Sell | $569,232 | 0.57% | 0.04% |
| Jun 04, 2024 | Sell | $867,409 | 2.50% | 0.06% |